Table 4 Associations between different albumin categories using 2-year serum albumin measurements with all-cause and cardiovascular mortality in the study population

 100 %

 75 to < 100 %

2.41

1.70–3.43

<0.001

2.01

1.41–2.87

<0.001

1.72

1.19–2.47

0.004

 50 to < 75 %

5.82

3.61–9.37

<0.001

3.64

2.22–5.95

<0.001

3.14

1.91–5.16

<0.001

 1 to < 50 %

7.20

4.43–11.69

<0.001

4.95

3.00–8.16

<0.001

3.66

2.18–6.16

<0.001

 0

8.10

3.25–20.14

<0.001

4.80

1.90–12.15

0.001

2.54

0.96–6.76

0.062

 Higher rate (75–100 %)

 Lower rate (0– < 75 %)

4.45

3.22–6.14

<0.001

3.11

2.23–4.35

<0.001

2.55

1.79–3.63

<0.001

 ≥4

 3.5 to < 4

2.38

1.54–3.68

<0.001

1.80

1.15–2.81

0.010

1.57

1.00–2.46

0.051

 <3.5

8.71

5.28–14.37

<0.001

4.84

2.84–8.26

<0.001

3.66

2.11–6.32

<0.001

 100 %

 75 to < 100 %

2.32

1.18–4.54

0.015

1.99

1.01–3.93

0.046

1.73

0.86–3.48

0.124

 50 to < 75 %

7.88

3.53–17.58

<0.001

4.78

2.09–10.96

<0.001

4.28

1.82–10.01

0.001

 1 to < 50 %

7.75

3.23–18.62

<0.001

4.69

1.91–11.49

0.001

3.23

1.22–8.54

0.018

 0

10.38

2.40–44.91

0.002

6.59

1.47–29.61

0.014

4.08

0.86–19.39

0.077

Albumin category

HR

95 % CI

P

HR

95 % CI

P

HR

95 % CI

P

 Higher rate (75–100 %)

 Lower rate (0– < 75 %)

5.88

3.31–10.45

<0.001

3.66

2.01–6.68

<0.001

2.94

1.58–5.47

0.001

 ≥4

 3.5 to < 4

2.02

0.93–4.42

0.076

1.51

0.68–3.36

0.315

1.28

0.57–2.90

0.552

 <3.5

8.94

3.74–21.37

<0.001

4.61

1.82–11.63

0.001

3.24

1.23–8.56

0.018